Medical Devices

Waystar Accelerates Impact in Healthcare Payments with New Innovations on Cloud-Based Platform

Businesswire | June 09, 2023 | Read time : 05:00 min

Waystar Accelerates Impact

Waystar, a leading provider of healthcare payments software, today announced significant enhancements across the company’s award-winning, cloud-based platform.

At a time of explosive growth in the accessibility and sophistication of technology, improved capabilities in areas such as artificial intelligence are playing a more significant role than ever in revolutionizing healthcare, particularly in administration and operations. Applied to the payments process, Waystar’s advances give patients and providers unparalleled clarity and accuracy, speed time to payment and connect processes and data to drive even higher levels of performance and insight.

“We are at a watershed moment in healthcare, where modern technology can drastically improve results for providers and their patients,” said Matt Hawkins, Chief Executive Officer of Waystar. “By unifying payments under a single cloud-based platform and harnessing the power of our purpose-built automation and analytics, we are removing friction from the system and helping providers focus on delivering care. I am energized by our team’s work to continually innovate and deliver on that mission.”

Spurred by recent leaps in automation and data analytics capabilities, Waystar is integrating groundbreaking new enhancements into its already industry-leading platform, unlocking

Transparency: Waystar’s solution is known for improving patient engagement, including enabling a 30% uptick in patient payments and 80% self-service pay rate, along with a patient Net Promoter Score (NPS) – which indicates a patient’s satisfaction with their payment experience at a provider – of 57 (Bain & Company, which developed the NPS benchmark, considers anything above a 50 ‘excellent’). With the addition of automated pre-claim coverage detection, clearer explanations of benefits (EOBs) and the delivery of estimates directly into the PatientWallet®, Waystar is bringing further clarity to patient obligations, drastically improving the overall financial experience and driving patient loyalty. Efficiency: From 340% increases in prior authorization speed to a 62% reduction in Medicare AR days, Waystar’s solution is recognized for the extreme efficiency it brings to healthcare payments. The company is now further enhancing its machine learning-infused claims follow-ups, which leverage data to better predict and guide follow-up actions for providers based on revenue impact. This advanced appeal prioritization, coupled with predictive analytics for authorization and denials workflows, is simplifying previously complex and time-intensive activities, reducing administrative burdens and empowering staff to focus their efforts on patient care. Accuracy: Built on the strength of a platform covering more than half of the U.S. patient population, Waystar is creating a precise process for providers that prevents revenue leakage and gets them paid fully and on time. Specifically, Waystar’s technology has spurred a 50% reduction in denials related to authorization and eligibility, achieved a 95% auditor agreement rate, and driven a 30% reduction in bad-debt write-offs for providers. Now, as the company introduces new claim attachments and next-generation analytic capabilities, providers can expect even less administrative waste in the payments process.

About Waystar

Through a smart platform and better experience, Waystar helps providers simplify healthcare payments and yield powerful results throughout the complete revenue cycle. Waystar’s healthcare payments platform combines innovative, cloud-based technology, robust data, and unparalleled client support to streamline workflows and improve financials so providers can focus on what matters most: their patients and communities. Waystar is trusted by 1M+ providers, 1K+ hospitals and health systems, and is connected to over 5K commercial and Medicaid/Medicare payers. Annually, Waystar’s AI-powered solutions process $6B+ patient payments, $4B+ out-of-pocket estimates, and claims for over 50% of U.S. patients.

Spotlight

Healthcare and life sciences companies face the difficult challenge of balancing the needs of the customer with the reality of doing business today. Macroeconomic conditions like inflation, supply chain issues, labor shortages, and sustainability have disrupted business as usual for this industry. When companies understand their

Spotlight

Healthcare and life sciences companies face the difficult challenge of balancing the needs of the customer with the reality of doing business today. Macroeconomic conditions like inflation, supply chain issues, labor shortages, and sustainability have disrupted business as usual for this industry. When companies understand their

Related News

Health Technology, Healthcare Analytics

AmeriPro Health expands to Kentucky and Indiana with acquisition of AMR's operations

prnewswire | August 07, 2023

AmeriPro Health, a leading provider of patient logistics and last-mile healthcare delivery services, has acquired American Medical Response, Inc.'s (AMR) operations in Lexington and Louisville, Kentucky, and New Albany, Indiana. As a result of the acquisition, AmeriPro Health now provides these three markets, which include UofL Health, University of Louisville Athletics and UK HealthCare, with its customizable suite of patient-centric 911, inter-facility medical transportation, critical care and advanced life support (ALS) services. "We're thrilled to bring AmeriPro's innovative last-mile services to Lexington, Louisville and New Albany," says Suhas Uppalapati, CEO of AmeriPro Health. "AmeriPro is steadfast in our commitment to revolutionize patient logistics. We aim to provide members of these communities - and blue-chip institutional partners such as UK HealthCare and UofL Health, along with other local hospitals, health plans and employers - with unmatched patient health services." This news follows AmeriPro's 2022 acquisition of CareMed, an ambulance service provider in Mississippi and Tennessee, and Ambulance Service, Inc., a longstanding Jacksonville, Florida-based EMS provider, in 2019. Established in 2018 with 10 ambulances in the Metro Atlanta area, AmeriPro Health has rapidly grown to 800+ employees with operations across six states. About AmeriPro Health AmeriPro Health encompasses a diverse range of healthcare companies devoted to optimizing patient logistics and last-mile healthcare delivery. Our extensive portfolio comprises emergency and critical care services, non-emergency medical transportation, patient coordination and personalized home-based care solutions, providing a seamless patient care journey. By covering the complete spectrum of patient care, we ensure enhanced patient outcomes, more efficient healthcare processes and timely, location-appropriate access to care. At AmeriPro Health, we provide an adaptable suite of patient-centric, value-driven services, tailored to meet the needs of communities, health systems, health plans and employers. As a pioneer in last-mile healthcare, our strength lies in our capacity to anticipate future needs, swiftly adapt and deliver on the evolving demands of our clients.

Read More

Health Technology, Healthcare Analytics

Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

PRNewswire | July 18, 2023

Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) reversal leader Virta Health have partnered to introduce Rx Reverse. Available to all of Capital Rx's customers, Rx Reverse is a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications. The problem is clear: 37+ million Americans have been diagnosed with diabetes, and over 90% of them have T2D (including one-third of the population over 65 years old).1 At the same time, the prevalence of obesity is over 40% of the U.S. population2 and is expected to reach nearly 50% by 2030.3 During a June 15, 2023 webinar, Rethinking Obesity Strategies: The Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss, Virta revealed new survey data highlighting that diabetes and obesity are the #1 and #2 concerns of health plan leaders in 2023 because of rising costs and downstream health impact. The launch of Rx Reverse comes as demand for GLP-1 drugs approved for diabetes and weight loss is rising rapidly, and employers and health plan leaders focus on managing the cost of diabetes and obesity. Rx Reverse combines Capital Rx's tech-enabled pharmacy benefit management (PBM) service model, powered by JUDI®, and Virta's solution – personalized nutrition therapy, physician-led deprescription, remote monitoring, and one-on-one coaching – to help health plans reduce costs and improve members' health. "Leveraging JUDI, our proprietary next-generation claim adjudication platform for Medicare, Medicaid, and commercial plans, we have the ability to seamlessly connect with vendors like Virta, sharing actionable member information efficiently in real-time, and providing the connectivity plan members need to improve their overall health," said Sara Izadi, PharmD, Senior Vice President of Pharmacy at Capital Rx. "Our Single-Ledger Model™, coupled with JUDI's capabilities, enables us to partner with Virta on a solution focused on deprescribing and health equity." Virta reports lowering HbA1c for patients by 1.3% on average after one year, and 60% of patients enrolled one year attained an HbA1c below 6.5% without using diabetes medications other than metformin. Moreover, patients experience an average of 12% body weight loss at two years. And like Capital Rx, which saves payers 10% - 30% in the first year, on average, after switching from a traditional PBM model, Virta emphasizes positive financial outcomes, including demonstrating an estimated $503 per engaged member per month gross savings for T2D reversal participants. Three Rx Reverse options are available for plan sponsors to choose from Type 2 Diabetes Reversal: Helps plan members achieve lower blood sugar – often to sub-diabetes levels <6.5 A1c – and clinically significant weight loss alongside safe deprescription of diabetes medication. Provider-Led Weight Loss: Helps plan members without diabetes who are considered overweight (BMI ≥ 25) or obese (BMI ≥ 30) achieve clinically significant weight loss. Type 2 Diabetes Reversal & Provider-Led Weight Loss "The rapidly rising utilization and cost of obesity and diabetes drugs is putting extreme pressure on healthcare payers," said Kevin Kumler, President at Virta Health. "Capital Rx's tech-forward, value-based approach – a needed evolution from the traditional PBM model – aligns both incentives and systems to help payers control drug costs while members get healthier." About Virta Health Virta Health is the leader in type 2 diabetes reversal and is creating a new standard in medical care for people living with type 2 diabetes, prediabetes, or obesity. The company's virtual approach combines personalized nutrition therapy with continuous provider-led support to empower members to eliminate medications, lose weight, and take back their lives. Virta has earned the trust of the nation's largest organizations, including Humana, AutoZone, and Blue Shield of California, delivering industry-leading cost savings of over $6,000 per member per year while putting our fees at risk based on health outcomes. About Capital Rx Capital Rx is a healthcare technology company changing the way prescription drugs are priced and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single-Ledger Model™, the industry's first ethical framework for drug pricing. The company's cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem, servicing over 2.4 million members for Medicare, Medicaid, and commercial plans.

Read More

Health Technology, Digital Healthcare

DrFirst Healthcare Innovations Collaborates with MEDITECH to Power E-Prescribing in Canada

PRNewswire | August 10, 2023

DrFirst Healthcare Innovations announced today it is collaborating with MEDITECH to enable electronic prescribing by hospitals using the Expanse EHR in Canada. This integration supports MEDITECH's plans with Canada Health Infoway to connect with its national e-prescribing service, PrescribeIT®. E-prescribing has numerous benefits for physicians, pharmacies, and patients, including eliminating the need for faxing or calling-in prescriptions to pharmacies, avoiding transcription errors, reducing the potential for fraud, and saving time for patients who no longer need to drop off a written prescription at the pharmacy. DrFirst Healthcare Innovations is integrated with the MEDITECH Expanse EHR to provide the directory of community pharmacies and to meet the complex technical requirements for secure electronic prescribing through PrescribeIT®. "E-prescribing is safer for patients and more efficient for prescribers and pharmacists," said G. Cameron Deemer, CEO of DrFirst Healthcare Innovations. "We have a long history of working with MEDITECH, and we are thrilled to collaborate on this initiative to introduce e-prescribing and accelerate its adoption in Canada to benefit patients, hospitals, and pharmacies." In May, MEDITECH announced that Humber River Health in Toronto, ON, will be MEDITECH's first hospital in Canada to implement PrescribeIT® within the Expanse EHR and is expected to go live with the technology this fall. "The introduction of e-prescribing in Canada is transformative. This integration with DrFirst Healthcare Innovations will further our collaboration with Canada Health Infoway and PrescribeIT® and ultimately provides safer and more efficient healthcare delivery, as well as greater convenience for patients," said Robert Molloy, MEDITECH Director, Canadian Market and Product Strategy. "The partnership between MEDITECH and DrFirst marks a significant step forward in PrescribeIT's mission to transform how prescriptions are sent and received," said Jamie Bruce, EVP, PrescribeIT®. "This collaboration will enhance patient care, streamline workflows, and empower healthcare professionals with a seamless and secure prescribing experience." DrFirst Healthcare Innovations is a long-time partner of MEDITECH in hospitals throughout the U.S. for e-prescribing and other medication management solutions, including augmented intelligence to increase productivity and streamline the collection of patients' medication history to better inform prescribing decisions. About DrFirst Healthcare Innovations Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management and has been active in Canada since 2015 via its wholly-owned subsidiary, DrFirst Healthcare Innovations. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of clinical-grade AI to streamline time-consuming healthcare workflows and prevent medication errors.

Read More